Server facts
heor-agent-mcp
Project
- Author
- neptun2000
- Repository
- github.com/neptun2000/heor-agent-mcp
- License
- MIT
- Category
- Data & Analytics
Tech
- Runtime / language
- node
- Transports
- stdio
- Remote available
- No
- Authentication
- Not specified
Activity
- GitHub stars
- 10
- Last commit
- Data as of
Tags
- cadth
- clinical trials
- ghevo
- health economics
- healthcare
- healtheconomics
- heor
- hta
- icer
- nice
- pharma
- pharmaceutical
- pubmed
Overview
Drug evidence, treatment comparisons and reimbursement submissions form the core of HEORAgent’s MCP toolset. Teams can search biomedical and HTA sources, screen abstracts against PICO criteria, retrieve available full text and assess study bias. Comparison tools map evidence networks, evaluate indirect-comparison feasibility and analyse supplied trial estimates. Economic tools cover cost effectiveness, budget impact, survival fitting and utility value sets. Search and modelling outputs can feed dossier drafts tailored to HTA bodies, while separate tools scope EU JCA questions and anticipate potential reviewer concerns. Bias assessments use abstract text and mark insufficiently reported domains as unclear.
For ongoing projects, a persistent knowledge base stores evidence, and a claim registry lets dossiers, publications and payer documents reuse recorded figures. Consistency checks flag numerical differences near claim keywords; they do not establish that every paraphrased statement agrees. Living-review tools compare refreshed searches with caller-provided records, while the living-evidence workflow generates a runbook rather than executing its steps or scheduling updates. Additional workflows address pharmacovigilance classification, ethics-review preparation and real-world evidence design. Population-adjusted comparisons are explicitly approximate, and simulated HTA panels require human review before submission use.
heor-agent-mcp setup notes
- heor-agent-mcp records stdio only; confirm a network transport upstream before planning remote access.